Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. (Q53974210)
Jump to navigation
Jump to search
scientific article
- Cabergoline in the treatment of early parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. |
scientific article |
|
Statements
Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group. (English)
1 reference
C D Marsden
1 reference
U K Rinne
1 reference
F Bracco
1 reference
C Chouza
1 reference
E Dupont
1 reference
O Gershanik
1 reference
J F Marti Masso
1 reference
J L Montastruc
1 reference
A Dubini
1 reference
N Orlando
1 reference
R Grimaldi
1 reference
1 February 1997
1 reference
1 reference
48
1 reference
2
1 reference
363-368
1 reference
Identifiers
1 reference